Together with the HPV-associated upregulation of ICOS-L and CD137-L following RCT, this provides another hint why HPV-positive HNSCC seem to be more immunogenic and thus have a better prognosis. This evidence concerns the gene TNFSF9 and head and neck squamous cell carcinoma.